# A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

> **NCT01055834** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Eszopiclone 3 mg
- **DRUG:** Eszopiclone 1 mg

## Key facts

- **NCT ID:** NCT01055834
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055834, "A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01055834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*